Centogene N.V.
NASDAQ:CNTG
Overview | Financials
Company Name | Centogene N.V. |
Symbol | CNTG |
Currency | USD |
Price | 0.325 |
Market Cap | 9,425,033 |
Dividend Yield | 0% |
52-week-range | 0.14 - 1.53 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Kim Stratton |
Website | https://www.centogene.com |
An error occurred while fetching data.
About Centogene N.V.
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD